ASTCT Applauds FDA Approval of Axatilimab-Csfr for the Treatment of Chronic Graft-Versus-Host Disease (cGVHD)
The American Society for Transplantation and Cellular Therapy (ASTCT) applauds the U.S. Food and Drug Administration’s (FDA) approval of axatilimab-csfr (Niktimvo, Incyte Corporation), a significant new...
GVHD Alliance to Honor Steven Pavletic With the Inaugural Lukas D. Wartman GVHD Achievement Award
First-ever award will be presented at the 2023 Tandem Meetings in conjunction with the inaugural GVHD Day on Friday, Feb. 17, 2023 In recognition of...